Published in Medicine and Law Weekly, July 6th, 2007
"Thermage is the first and only company to receive FDA clearance for non-invasive eyelid treatments," said Stephen J. Fanning, president and chief executive officer at Thermage. "We believe that the clinical data supporting this milestone further defines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.